Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
5 Patents
#50 in Melbourne
#799 in Australia
Fibrotech Therapeutics Pty Ltd
Forward Citations = 41
7 inventors:
Fibrotech Therapeutics Pty Ltd
% Expired Patents = 20.0
EPO Patents = 6
Forward Citations = 41
Loading Chart...
Loading Chart...
7 inventors (with patents filed for the assignee):
Darren James Kelly (5 out of 9 patents)
Steven Zammit (5 out of 5 patents)
Spencer John Williams (4 out of 11 patents)
4. David Stapleton (2 out of 6 patents)
5. Richard Ernest Gilbert (2 out of 3 patents)
6. Henry Krum (2 out of 2 patents)
7. Spencer John Willams (1 out of 1 patent)
5 patents:
Company Overview
Fibrotech Therapeutics is a biotechnology company focused on developing innovative therapies for fibrotic diseases. Their proprietary platform enables the discovery and development of novel compounds that target fibrosis, offering new hope for patients with conditions such as pulmonary fibrosis, liver cirrhosis, and renal fibrosis.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fibrotech Therapeutics Pty Ltd. Retrieved from https://idiyas.com/company/fibrotech-therapeutics-pty
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
6 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]